Alpha 2.0
Login Register
» Authors » A J M Verhoeven

A J M Verhoeven

Explore the profile of A J M Verhoeven including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 85
Followers 0
Related Specialties
Endocrinology
General Medicine
Cell Biology
Top 10 Co-Authors
M T Mulder
E J G Sijbrands
R Yahya
W A Dik
J E Roeters van Lennep
D K Das
P J M Leenen
K Bezstarosti
N Gurusamy
S Jainandunsing
Published In
J Cell Mol Med
Atherosclerosis
Atheroscler Plus
Diabetologia
Clin Nutr ESPEN
Affiliations
Soon will be listed here.
Recent Articles
1.
Breakfast partly restores the anti-inflammatory function of high-density lipoproteins from patients with type 2 diabetes mellitus
Lemmers R, Martens N, Maas A, van Vark-van der Zee L, Leijten F, Groot-van Ruijven C, et al.
Atheroscler Plus . 2023 Jan; 44:43-50. PMID: 36644668
Background And Aims: High-density lipoproteins (HDL) of patients with type 2 diabetes mellitus (T2DM) have impaired anti-inflammatory activities. The anti-inflammatory activity of HDL has been determined after isolation by different...
2.
HDL associates with insulin resistance and beta-cell dysfunction in South Asian families at risk of type 2 diabetes
Yahya R, Jainandunsing S, Rashid M, van der Zee L, Touw A, de Rooij F, et al.
J Diabetes Complications . 2021 Aug; 35(10):107993. PMID: 34384708
Objective: Dyslipidemia precedes type 2 diabetes (T2D) and worsens with increasing glucose intolerance. First degree relatives of T2D patients have an increased risk to develop dyslipidemia and glucose intolerance. The...
3.
Diet-induced weight loss and markers of endothelial dysfunction and inflammation in treated patients with type 2 diabetes
Berk K, Oudshoorn T, Verhoeven A, Mulder M, Roks A, Dik W, et al.
Clin Nutr ESPEN . 2017 May; 15:101-106. PMID: 28531772
Background & Aims: Overweight and obesity increase cardiovascular mortality in patients with type 2 diabetes (T2D). In a recent trial, however, diet-induced weight loss did not reduce the cardiovascular risk...
4.
Lomitapide affects HDL composition and function
Yahya R, Favari E, Calabresi L, Verhoeven A, Zimetti F, Adorni M, et al.
Atherosclerosis . 2016 May; 251:15-18. PMID: 27232459
Background: Lomitapide reduces low-density lipoprotein-cholesterol (LDL-C) but also high-density lipoprotein-cholesterol (HDL-C) levels. The latter may reduce the clinical efficacy of lomitapide. We investigated the effect of lomitapide on HDL-C levels...
5.
Lipoprotein(a) levels are associated with aortic valve calcification in asymptomatic patients with familial hypercholesterolaemia
Vongpromek R, Bos S, Ten Kate G, Yahya R, Verhoeven A, de Feyter P, et al.
J Intern Med . 2014 Dec; 278(2):166-73. PMID: 25487646
Objectives: Lipoprotein(a) [Lp(a)] is an independent risk factor for aortic valve stenosis and aortic valve calcification (AVC) in the general population. In this study, we determined the association between AVC...
6.
Glucose increases hepatic lipase expression in HepG2 liver cells through upregulation of upstream stimulatory factors 1 and 2
van Deursen D, Jansen H, Verhoeven A
Diabetologia . 2008 Sep; 51(11):2078-87. PMID: 18758746
Aims/hypothesis: Elevated hepatic lipase (HL, also known as LIPC) expression is a key factor in the development of the atherogenic lipid profile in type 2 diabetes and insulin resistance. Recently,...
7.
Identification by a differential proteomic approach of the induced stress and redox proteins by resveratrol in the normal and diabetic rat heart
Dekkers D, Bezstarosti K, Gurusamy N, Luijk K, Verhoeven A, Rijkers E, et al.
J Cell Mol Med . 2008 Jan; 12(5A):1677-89. PMID: 18194459
A recent study showed cardioprotective effects of resveratrol on the diabetic heart. The present study sought to compare the protein profiles of the normal versus diabetic hearts after resveratrol treatment...